JPRN-UMIN000004807已完成未知
Phase I/II study of Gefitnib monotherapy as neo-adjuvant chemotherapy for cN2 lung adenocarcinoma with the EGFR mutation - Phase I/II study of Gefitnib monotherapy as neo-adjuvant chemotherapy for cN2 lung adenocarcinoma with the EGFR mutation
KantoKoshinetsu lung cancer research group0 个研究点目标入组 20 人开始时间: 2010年12月29日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) patients who has interstitial pneumonia identified by chest CT or by blood test (2) (3) Patients with EGFR mutation (T790M) which is NOT expected the good response with gefitinib. (4) Patients with uncontrollable complications (5) Pregnant or lactation women, or women with known or suspected pregnancy (6) Patients with severe malabsorption syndrome or with severe functional gastrointestinal disorder (7) patients with systemic administration steroids over 4 weeks (8) Patients with contraindication of gefitinib (9) Patients with active concomitant malignancy (10) Inappropriate patients for this study judged by the physicians
研究者
相似试验
已完成
2 期
A Phase II Study of Gefitinib Monotherapy as First-Line Treatment for Elderly Patients with Stage IIIB /IV Adenocarcinoma of the LungJPRN-UMIN000006144Central Japan Lung Study Group32
已完成
不适用
Clinical study of a combined use of Gefitinib and autologous lymphocyte-activated killer cells (LAK) therapy for advanced non-small cell lung cancer.non-small cell lung cancerJPRN-UMIN000000637Juntendo University, School of Medicine20
招募中
不适用
Efficacy and safety of gefitinib monotherapy for all types of refractory cancer patients with EGFR amplificatioKCT0004066Samsung Medical Center3
已完成
2 期
A Phase II study of Gefitinib as First-Line Treatment for Elderly Patients with Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations.on-Small-Cell Lung CancerJPRN-UMIN000001863Central Japan Lung Study Group19
已完成
不适用
Analysis of Gefitinib(Drug) in lung cancer.CTRI/2017/05/008490Tata Memorial Hospital350